Actively Recruiting
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
Led by Sahlgrenska University Hospital · Updated on 2025-04-09
580
Participants Needed
1
Research Sites
342 weeks
Total Duration
On this page
Sponsors
S
Sahlgrenska University Hospital
Lead Sponsor
V
Vastra Gotaland Region
Collaborating Sponsor
AI-Summary
What this Trial Is About
Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.
CONDITIONS
Official Title
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty
- Ability to understand and write Swedish
You will not qualify if you...
- Impaired function of the other hip or knees causing limping
- Neuromuscular diseases
- Postoperative leg length difference exceeding 1 cm
- Postoperative difference in femoral offset exceeding 25% compared to the other hip
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sahlgrenska University Hospital
Mölndal, Sweden, 431 80
Actively Recruiting
Research Team
G
Georgios Tsikandylakis, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here